Clinical Trial: Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517445) titled 'Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis' on April 01.

Brief Summary: The purpose of this study is to determine if nicotinamide in combination with bedaquiline, pretomanid, and linezolid, is safe and effective in treating drug-susceptible pulmonary tuberculosis.

Study Start Date: April 13

Study Type: INTERVENTIONAL

Condition: Drug Susceptible Pulmonary Tuberculosis

Intervention: DRUG: Bedaquiline, pretomanid, linezolid

Group 1 (Approximately 55 participants), Combination of NAM 1500 mg twice daily (BID) with bedaquili...